Skip to main content

Table 3 Summary of Overall Response Rate (ORR)

From: Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

All patients

(n = 42)

Number

Percent

Histology

42

 

Adenocarcinoma

 ORR

7/20

35.0

Squamous cell carcinoma

 ORR

11/22

50.0

p = 0.367a

EGFR mutation status

24

 

Positive

 ORR

0/2

0

Wild-type

 ORR

8/22

36.4

p = 0.536a

 PD-L1 (TPS)

10

 

≥1%

 ORR

5/8

62.5

< 1%

 ORR

2/2

100.0

p = 0.467a

  1. aFisher’s exact test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us